Agilus Diagnostics Ltd IPO

Experienced pan-India diagnostics service provider with a diversified presence and a growing network that is well positioned to capitalize on the expected growth in the Indian diagnostics industry.

Comprehensive test offerings providing one stop solution for diagnostic requirements.

Advanced information technology platform supported by integrated systems enabling customer-centric initiatives.

Well-balanced B2C and B2B revenue mix.

The company recently changed its brand which led to certain legal proceedings that are currently pending before the Delhi High Court. Any unfavorable outcome may have an adverse effect on its business, reputation, results of operations and financial condition.

Any failure to establish its new brand may adversely affect customer confidence in the company services or its inability to maintain and enhance its brand and reputation or any negative publicity and allegations, may have an adverse impact on its business, reputation, results of operations and financial condition.

Its trade mark applications in relation to its new brand, "Agilus Diagnostics" and "Agilus" are not yet registered, and some have been objected/ opposed by other parties. Any inability to obtain registration or otherwise protect its intellectual property rights, or any exposure to misappropriation and infringement claims by third parties, could have an adverse effect on its business, reputation, financial condition and results of operations.

Its Promoter, Fortis Healthcare Limited, is subject to certain regulatory and statutory proceedings, including an appeal pending before the Securities Appellate Tribunal and an ongoing investigation by the Serious Fraud Investigation Office for certain alleged improper transactions and non-compliance with applicable laws and regulations including the Companies Act. Any prolonged proceedings or adverse outcome of such proceedings in the future may have an adverse impact on its business and reputation.